Development of Recifercept, a FGFR3 decoy protein, as a potential treatment for Achondroplasia

被引:0
|
作者
Czech, Christian
Slade, Alison
Goncalves, Diogo
Roberts, Kevin
Dawra, Vikas Kumar
Rignol, Guylene
机构
[1] Pfizer, Paris, France
[2] Pfizer, Zurich, Switzerland
[3] Pfizer, New York, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT-647
引用
收藏
页码:170 / 170
页数:1
相关论文
共 50 条
  • [41] Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation
    Couser, Natario L.
    Pande, Chetna K.
    Turcott, Christie M.
    Spector, Elaine B.
    Aylsworth, Arthur S.
    Powell, Cynthia M.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2017, 173 (04) : 1097 - 1101
  • [42] Knock-in human FGFR3 achondroplasia mutation as a mouse model for human skeletal dysplasia
    Yi-Ching Lee
    I-Wen Song
    Ya-Ju Pai
    Sheng-De Chen
    Yuan-Tsong Chen
    Scientific Reports, 7
  • [43] Postnatal Soluble FGFR3 Therapy Rescues Achondroplasia Symptoms and Restores Bone Growth in Mice
    Garcia, Stephanie
    Dirat, Beatrice
    Tognacci, Thomas
    Rochet, Nathalie
    Mouska, Xavier
    Bonnafous, Stephanie
    Patouraux, Stephanie
    Albert Tran
    Gual, Philippe
    Le Marchand-Brustel, Yannick
    Gennero, Isabelle
    Gouze, Elvire
    SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (203)
  • [44] A novel mutation Ser344Cys in FGFR3 causes achondroplasia with severe platyspondyly
    Takagi, Masaki
    Kouwaki, Masanori
    Kawase, Koya
    Shinohara, Hiroyuki
    Hasegawa, Yukihiro
    Yamada, Takahiro
    Fujiwara, Ikuma
    Sawai, Hideaki
    Nishimura, Gen
    Hasegawa, Tomonobu
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2015, 167 (11) : 2851 - 2854
  • [45] Meclozine Facilitates Proliferation and Differentiation of Chondrocytes by Attenuating Abnormally Activated FGFR3 Signaling in Achondroplasia
    Matsushita, Masaki
    Kitoh, Hiroshi
    Ohkawara, Bisei
    Mishima, Kenichi
    Kaneko, Hiroshi
    Ito, Mikako
    Masuda, Akio
    Ishiguro, Naoki
    Ohno, Kinji
    PLOS ONE, 2013, 8 (12):
  • [46] Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gene
    Pehlivan, S
    Özkinay, F
    Okutman, Ö
    Çogulu, Ö
    Özcan, A
    Çankaya, T
    Ülgenalp, A
    TURKISH JOURNAL OF PEDIATRICS, 2003, 45 (02) : 99 - 101
  • [47] Compound heterozygosity for the achondroplasia-hypochondroplasia FGFR3 mutations: Prenatal diagnosis and postnatal outcome
    Chitayat, D
    Fernandez, B
    Gardner, A
    Moore, L
    Glance, P
    Dunn, M
    Chun, K
    Sgro, M
    Ray, P
    Allingham-Hawkins, D
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1999, 84 (05): : 401 - 405
  • [48] Fgfr3 enhancer deletion markedly improves all skeletal features in a mouse model of achondroplasia
    Angelozzi, Marco
    Molin, Arnaud
    Karvande, Anirudha
    Fernandez-Iglesias, Angela
    Whipple, Samantha
    Bloh, Andrew M.
    Lefebvre, Veronique
    JOURNAL OF CLINICAL INVESTIGATION, 2025, 135 (02):
  • [49] MUTATIONS IN THE TRANSMEMBRANE DOMAIN OF FGFR3 CAUSE THE MOST COMMON GENETIC FORM OF DWARFISM, ACHONDROPLASIA
    SHIANG, R
    THOMPSON, LM
    ZHU, YZ
    CHURCH, DM
    FIELDER, TJ
    BOCIAN, M
    WINOKUR, ST
    WASMUTH, JJ
    CELL, 1994, 78 (02) : 335 - 342
  • [50] Knock-in human FGFR3 achondroplasia mutation as a mouse model for human skeletal dysplasia
    Lee, Yi-Ching
    Song, I-Wen
    Pai, Ya-Ju
    Chen, Sheng-De
    Chen, Yuan-Tsong
    SCIENTIFIC REPORTS, 2017, 7